• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与氰基石墨烯/Ag 纳米杂化材料联合处理恢复失活抗生素的抗菌活性。

Restoration of antibacterial activity of inactive antibiotics via combined treatment with a cyanographene/Ag nanohybrid.

机构信息

Department of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.

Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Křížkovského 511/8, 779 00, Olomouc, Czech Republic.

出版信息

Sci Rep. 2022 Mar 25;12(1):5222. doi: 10.1038/s41598-022-09294-7.

DOI:10.1038/s41598-022-09294-7
PMID:35338239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8956642/
Abstract

The number of antibiotic-resistant bacterial strains is increasing due to the excessive and inappropriate use of antibiotics, which are therefore becoming ineffective. Here, we report an effective way of enhancing and restoring the antibacterial activity of inactive antibiotics by applying them together with a cyanographene/Ag nanohybrid, a nanomaterial that is applied for the first time for restoring the antibacterial activity of antibiotics. The cyanographene/Ag nanohybrid was synthesized by chemical reduction of a precursor material in which silver cations are coordinated on a cyanographene sheet. The antibacterial efficiency of the combined treatment was evaluated by determining fractional inhibitory concentrations (FIC) for antibiotics with different modes of action (gentamicin, ceftazidime, ciprofloxacin, and colistin) against the strains Escherichia coli, Pseudomonas aeruginosa, and Enterobacter kobei with different resistance mechanisms. Synergistic and partial synergistic effects against multiresistant strains were demonstrated for all of these antibiotics except ciprofloxacin, which exhibited an additive effect. The lowest average FICs equal to 0.29 and 0.39 were obtained for colistin against E. kobei and for gentamicin against E. coli, respectively. More importantly, we have experimentally confirmed for the first time, that interaction between the antibiotic's mode of action and the mechanism of bacterial resistance strongly influenced the combined treatment's efficacy.

摘要

由于抗生素的过度和不适当使用,导致抗生素耐药菌株的数量不断增加,因此抗生素的疗效正在下降。在这里,我们报告了一种通过将抗生素与一种新型纳米材料——氰基石墨烯/银纳米杂化材料联合应用来增强和恢复抗生素抗菌活性的有效方法。该纳米杂化材料是通过在氰基石墨烯片上配位银离子的前体制备,并通过化学还原法合成的。通过测定不同作用模式(庆大霉素、头孢他啶、环丙沙星和黏菌素)的抗生素对具有不同耐药机制的大肠杆菌、铜绿假单胞菌和产酸克雷伯菌的菌株的部分抑菌浓度(FIC),评估了联合治疗的抗菌效率。除了环丙沙星表现出相加作用外,所有这些抗生素对多耐药菌株均表现出协同和部分协同作用。对于黏菌素对产酸克雷伯菌和庆大霉素对大肠杆菌的作用,获得了最低的平均 FIC 值,分别为 0.29 和 0.39。更重要的是,我们首次通过实验证实,抗生素作用模式与细菌耐药机制之间的相互作用强烈影响联合治疗的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/44e951719821/41598_2022_9294_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/4069af28d06f/41598_2022_9294_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/a4930c870a67/41598_2022_9294_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/44e951719821/41598_2022_9294_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/4069af28d06f/41598_2022_9294_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/a4930c870a67/41598_2022_9294_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bd/8956642/44e951719821/41598_2022_9294_Fig3_HTML.jpg

相似文献

1
Restoration of antibacterial activity of inactive antibiotics via combined treatment with a cyanographene/Ag nanohybrid.通过与氰基石墨烯/Ag 纳米杂化材料联合处理恢复失活抗生素的抗菌活性。
Sci Rep. 2022 Mar 25;12(1):5222. doi: 10.1038/s41598-022-09294-7.
2
Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae.银纳米颗粒强烈增强并恢复了失活抗生素对多重耐药肠杆菌科的杀菌活性。
Colloids Surf B Biointerfaces. 2016 Jun 1;142:392-399. doi: 10.1016/j.colsurfb.2016.03.007. Epub 2016 Mar 4.
3
In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.环丙沙星与氨基糖苷类药物对多重耐药铜绿假单胞菌的体外协同作用
Pak J Pharm Sci. 2013 Sep;26(5):1041-4.
4
In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.舒巴坦与不同抗生素组合对临床鲍曼不动杆菌分离株的体外作用
J Chemother. 2012 Oct;24(5):247-52. doi: 10.1179/1973947812Y.0000000029.
5
In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.黏菌素与头孢他啶或环丙沙星对多重耐药铜绿假单胞菌临床菌株的体外协同活性。
Microb Drug Resist. 2014 Dec;20(6):550-4. doi: 10.1089/mdr.2014.0006.
6
Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model.黏菌素与头孢他啶在体外药效学模型中对多重耐药铜绿假单胞菌的协同活性。
Antimicrob Agents Chemother. 2003 Mar;47(3):905-9. doi: 10.1128/AAC.47.3.905-909.2003.
7
Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.芫荽精油和芳樟醇——与抗生素对革兰氏阳性菌和革兰氏阴性菌的相互作用
Lett Appl Microbiol. 2019 Feb;68(2):156-164. doi: 10.1111/lam.13100. Epub 2019 Jan 4.
8
New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.氟西汀在药理学中的新作用:抗菌作用和抗生素活性的调节。
Microb Pathog. 2018 Oct;123:368-371. doi: 10.1016/j.micpath.2018.07.040. Epub 2018 Jul 26.
9
Antibacterial activity of colistin is resurrected by Stephania suberosa Forman extract against colistin-resistant Enterobacter cloacae.蛇葡萄提取物复活多黏菌素耐药阴沟肠杆菌的抗菌活性。
Lett Appl Microbiol. 2019 Aug;69(2):128-135. doi: 10.1111/lam.13187. Epub 2019 Jun 18.
10
Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.两种抗菌肽(乳链菌肽和 P10)与常规抗生素联合对抗广泛耐药鲍曼不动杆菌和耐多粘菌素铜绿假单胞菌的协同作用。
Microb Pathog. 2021 Jan;150:104700. doi: 10.1016/j.micpath.2020.104700. Epub 2020 Dec 17.

引用本文的文献

1
Silver Nanoparticles (AgNPs) from sp. Culture Broths: Antibacterial Activity, Mechanism Insights, and Synergy with Classical Antibiotics.来自特定菌种培养液的银纳米颗粒(AgNPs):抗菌活性、作用机制洞察以及与传统抗生素的协同作用
Biomolecules. 2025 May 16;15(5):731. doi: 10.3390/biom15050731.
2
Silver Nanoparticles and Antibiotics: A Promising Synergistic Approach to Multidrug-Resistant Infections.银纳米颗粒与抗生素:应对多重耐药感染的一种有前景的协同方法。
Microorganisms. 2025 Apr 21;13(4):952. doi: 10.3390/microorganisms13040952.
3
Strategies for Overcoming Bacterial Resistance to Nanoparticles: A Systematic Review.

本文引用的文献

1
Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics.银键合到氰基石墨烯上克服了细菌对银纳米粒子和抗生素的耐药性。
Adv Sci (Weinh). 2021 May 3;8(12):2003090. doi: 10.1002/advs.202003090. eCollection 2021 Jun.
2
Implementation of Antibiotic Stewardship in a University Hospital Setting.大学医院环境中抗生素管理的实施
Antibiotics (Basel). 2021 Jan 19;10(1):93. doi: 10.3390/antibiotics10010093.
3
Synergistic Antibacterial Activity of Silver-Loaded Graphene Oxide towards and .
克服细菌对纳米颗粒耐药性的策略:一项系统综述
Cureus. 2025 Jan 27;17(1):e78064. doi: 10.7759/cureus.78064. eCollection 2025 Jan.
4
E. coli and S. aureus resist silver nanoparticles via an identical mechanism, but through different pathways.大肠杆菌和金黄色葡萄球菌通过相同的机制但通过不同的途径来抵抗银纳米粒子。
Commun Biol. 2024 Nov 21;7(1):1552. doi: 10.1038/s42003-024-07266-3.
5
Unraveling resistance mechanisms in combination therapy: A comprehensive review of recent advances and future directions.解析联合治疗中的耐药机制:近期进展与未来方向的全面综述
Heliyon. 2024 Mar 11;10(6):e27984. doi: 10.1016/j.heliyon.2024.e27984. eCollection 2024 Mar 30.
6
Comparative analysis of the antibacterial efficacy and bioactive components of Thuja occidentalis obtained from four different geographical sites.比较分析四个不同产地的西洋杉的抗菌功效和生物活性成分。
Mol Cell Biochem. 2024 Feb;479(2):283-296. doi: 10.1007/s11010-023-04729-9. Epub 2023 Apr 15.
7
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections.近年来,针对铜绿假单胞菌感染的治疗靶点的鉴定和治疗策略的发展取得了进展。
BMC Microbiol. 2023 Mar 30;23(1):86. doi: 10.1186/s12866-023-02832-x.
载银氧化石墨烯对[具体对象1]和[具体对象2]的协同抗菌活性 。 (你原文中towards后面内容缺失,请补充完整以便我给出更准确译文)
Nanomaterials (Basel). 2020 Feb 20;10(2):366. doi: 10.3390/nano10020366.
4
Heritable nanosilver resistance in priority pathogen: a unique genetic adaptation and comparison with ionic silver and antibiotics.优先病原体中可遗传的纳米银抗性:一种独特的遗传适应性,并与离子银和抗生素进行比较。
Nanoscale. 2020 Jan 28;12(4):2384-2392. doi: 10.1039/c9nr08424j. Epub 2020 Jan 13.
5
Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌中青霉素和β-内酰胺酶抑制剂隐匿性易感性的基因组鉴定。
Nat Microbiol. 2019 Oct;4(10):1680-1691. doi: 10.1038/s41564-019-0471-0. Epub 2019 Jun 24.
6
Silver-Based Plasmonic Nanoparticles for and Their Use in Biosensing.基于银的等离子体纳米粒子及其在生物传感中的应用。
Biosensors (Basel). 2019 Jun 10;9(2):78. doi: 10.3390/bios9020078.
7
Antibacterial Properties of Graphene-Based Nanomaterials.基于石墨烯的纳米材料的抗菌性能
Nanomaterials (Basel). 2019 May 13;9(5):737. doi: 10.3390/nano9050737.
8
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?美国传染病学会的 10×20 倡议(10 种新的全身性抗菌药物于 2020 年获得美国食品和药物管理局批准):20×20 是否有可能?
Clin Infect Dis. 2019 Jun 18;69(1):1-11. doi: 10.1093/cid/ciz089.
9
Antibacterial Carbon-Based Nanomaterials.抗菌碳基纳米材料。
Adv Mater. 2019 Nov;31(45):e1804838. doi: 10.1002/adma.201804838. Epub 2018 Oct 31.
10
In Vitro Synergism of Silver Nanoparticles with Antibiotics as an Alternative Treatment in Multiresistant Uropathogens.银纳米颗粒与抗生素的体外协同作用作为多重耐药尿路病原体的替代治疗方法
Antibiotics (Basel). 2018 Jun 19;7(2):50. doi: 10.3390/antibiotics7020050.